Virtual Teach to Goal vs. Brief Intervention Inhaler Study-outpatient
NCT ID: NCT04470180
Last Updated: 2022-02-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
100 participants
INTERVENTIONAL
2020-08-01
2021-11-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
vDOT for Newly Diagnosed Pediatric Asthma
NCT05120323
Video-based Teach-to-goal Intervention on Inhaler Technique on Jordanian Adults With Asthma and COPD
NCT05664347
Asthma Inpatient Research on Education
NCT02948738
Optimising Inhaler Technique and Asthma Self-management in Children and Young People
NCT06531096
AQI and Childhood Asthma: an Intervention
NCT04454125
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Effective self-management is crucial to optimize asthma care and improve outcomes. A key barrier to self-management is the improper use of respiratory inhalers, which limits disease control. Better inhaler technique is associated with improved asthma outcomes for children. Assessment and education of inhaler technique are recommended at all healthcare encounters; however, it is limited in practice because it is resource-intensive (both personnel and time) and lacks fidelity. Thus, low-resource interventions that accurately teach inhaler skills are needed to impact pediatric asthma outcomes.
Teach-to-Goal (TTG) is a patient-centered strategy that uses tailored rounds of teaching and assessments to ensure mastery of inhaler technique. Studies show it is effective but resource-intensive. A "virtual TTG" (V-TTG) intervention represents an opportunity to deliver inhaler technique education with a high-fidelity, low-resource, and feasible strategy. The module utilizes innovative learning technology with video demonstrations and assessment questions to tailor education to each user; the cycles of assessment and education continues until satisfactory mastery is achieved. Our team developed a V-TTG intervention for adults with demonstrated efficacy. It remains unknown whether this interactive and adaptive module will be feasible and effective in the pediatric population due to varied developmental levels and parental involvement in care.
Virtual Teach-to-Goal (V-TTG) holds the potential to improve inhaler technique in children; however, because learning theory indicates children and adults learn differently, the same learning module cannot be utilized. We have already constructed V-TTG for children with feedback from children with asthma, parents, and healthcare professionals. The learning module is tailored for age by using developmentally and age-appropriate vocabulary, concepts, format, and pacing.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Virtual Teach-to-Goal (V-TTG)
They will be randomized to receive education via a virtual learning module.
Virtual Teach to Goal
Participants will complete inhaler education on a tablet device.
standardized brief intervention
Intervention that mimics usual care to deliver inhaler technique education.
Brief Instruction
Participants will be read out loud instruction on how to use their inhaler.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Virtual Teach to Goal
Participants will complete inhaler education on a tablet device.
Brief Instruction
Participants will be read out loud instruction on how to use their inhaler.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. The child is between the ages of 6-17 years old
2. The child has a diagnosis of asthma, wheezing, or bronchospasm
3. The child has been or is seen in general pediatrics, pediatric pulmonary, or pediatric allergy clinic at the University of Chicago Medical Center
4. The child is taking medication for asthma, wheezing, or bronchospasm (either a controller medication or a quick-relief medication)
5. The family has acess to wifi and/or data that supports virtual video-based platforms (if study is done virtually)
Exclusion Criteria
1. The child/parent decline or unable to provide consent/assent
2. The child/parent does not speak/read English
3. The child cannot use an inhaler by themselves without a mask
4. The child previously participated in this study
5. The family does not have access to wifi and/or data that supports virtual video-based platforms (if study done virtually)
6 Years
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
American Thoracic Society
OTHER
University of Chicago
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anna Volerman, MD
Role: PRINCIPAL_INVESTIGATOR
University of Chicago
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Chicago Medicine
Chicago, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
192091
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.